This is a compilation of researches on drugs and drug abuse prevention and control undertaken by various research entities and educational institutions, including studies which can be found in different libraries.

• Alcohol Drinking Patterns Among High School Students in a Government and Private Secondary School in Southern Philippines
• An Assessment of the Clinical Personality Patterns and Psychological Needs of Selected Institutionalized Male Drug Abusers: Implications for an Adjunctive Intervention Program
• An Evaluation of the Addiction Recovery Meetings in Tatalon, Quezon City
• An Evaluation of the Residential Treatment Program of Narcotics Group (NARGROUP) Rehabilitation Center Using Stufflebeam’s CIPP Model
• Baseline Survey of Treatment Outcomes Utilizing Therapeutic Community in Government Substance Abuse Treatment and Rehabilitation Centers: The Philippine Experience
• Description of Areca Nut Use in a Cordilleran Community
• Drug and Substance Use Among Filipino Street Children in an Urban Setting: A Qualitative Study
• Drug Defined Crimes Among Inmates in a City Jail in Eastern Visayas, Philippines
• Pastoral Care for Drug Addicts in Vietnam: Theologico-Pastoral Implications
• Prior Sexual Abuse Among Female Substance Dependents Admitted in DOH-TRC in Metro Manila
• “Ready or Unready?” Factors Related to the Motivation for Change Among Drug Dependents Admitted in a Government Drug Treatment and Rehabilitation Center in Metro Manila
• The Effect of Forgiveness Intervention Program on Substance Dependence
• The Prevalence of Anxiety and Depression Among Adult Substance Abusers Admitted at Government Drug Treatment and Rehabilitation Centers in the Philippines
• The Upshot of the Implementation of a Drug-Free Workplace Program to the Employees of the City Government of Muntinlupa

#REALNUMBERSPH YEAR 2

      

 

#REALNUMBERSPH YEAR 3

 

#REALNUMBERSPH YEAR 4

 

 

#REALNUMBERSPH YEAR 5

 

 

ADVISORIES FROM 2022

Advisory to our stakeholders when applying for Certification and Exemption using the Online Application for Certification and Exemption Information System (OACEIS)

Advisory to our stakeholders when applying for Certification and Exemption using the Online Application for Certification and Exemption Information System (OACEIS)

 

Submission of IDADIN Semi-Annual Report (SAR) through Electronic Mail and the Dangerous Drugs and Controlled Precursors & EssentialsChemicals Monitoring System (DDCPEC-MS)

 

Submission of IDADIN Semi-Annual Report (SAR) through Electronic Mail and the Dangerous Drugs and Controlled Precursors & Essential Chemicals Monitoring System (DDCPEC-MS)

 

 

Payment Transactions (02 JAN 2022)

 

 

Supplemental Advisory on the Submission of IDADIN Semi-Annual Report (SAR)

Supplemental Advisory on the Submission of IDADIN Semi-Annual Report (SAR)

The Dangerous Drugs Board would like to clarify that only reports for Dangerous Drugs and Pure Controlled Precursors and Essential Chemicals will be part of the pilot test and parallel implementation of the Dangerous Drugs and Controlled Precursors and Essential Chemicals Monitoring System (DDCPEC-MS). All reports on these will have to be submitted in two concurrent ways – through the DDCPEC-MS at https://ddcpec.ddb.gov.ph/Security/SignIn.aspx and through email at cs.sar@pdea.gov.ph.

For mixtures, reports will have to be submitted only through email at lad@ddb.gov.ph. For those stakeholders who had already submitted their reports to legaldivision.ddb@gmail.com, please resend your reports at lad@ddb.gov.ph.

The submission of the Semi-Annual Report must be done not later than 15 January 2022.

Advisory for the Cancellation of Delayed Payment

Advisory for the Cancellation of Delayed Payment

In line with the issuance of the amended guidelines on the nationwide implementation of the Alert Level System for Covid-19 response (Subject: Guidelines on the Nationwide Implementation of Alert Level System for COVID-19 Respose as of February 27, 2022) by the Inter-Agency Task Force for the Management of Emerging Infectious Diseases (IATF-EID) placing the National Capital Region and 38 other areas under Alert Level 1 since 01 March 2022, the Dangerous Drugs Board issues the following guidelines. (download full advisory on the link below)

Issued this 24th day of March 2022 in Quezon City, Philippines.

Undersecretary EARL P. SAAVEDRA
Executive Director

Click here to download the advisory.

 

Seminar-Workshop on Developing Effective Public Awareness Campaign Against Drug Use and Illicit Trafficking on June 27, 2022

Seminar-Workshop on Developing Effective Public Awareness Campaign Against Drug Use and Illicit Trafficking on June 27, 2022

Let your creative juices flow! Design effective public awareness campaign materials and let’s win our war against drugs together!

Register now for the Seminar-Workshop on Developing Effective Public Awareness Campaign Against Drug Use and Illicit Trafficking to be held on June 27, 2022.

Click this link: https://tinyurl.com/careincrises

Seminar link: https://tinyurl.com/WorldDrugDay

#IDADAIT2022
#InternationalDayAgainstDrugAbuseAndIllicitTrafficking
#CareInCrises
#WorldDrugDay

 

Advisory for Maintenance Activities of Information Systems

ADVISORY:

The DDB will conduct maintenance activities of its information systems from 8:00 AM of June 11 to 5:00 PM of June 12. During this period, our information systems will be inaccessible. All information systems will be back online after the maintenance activity. Kindly re-schedule any planned transactions using these systems during the scheduled downtime. Thank you.

 

Advisory for July 08, 2022

Advisory:

The DDB Information systems will be temporarily unavailable from 4:00 PM of July 2022 to 5:00 PM of 09 July 2022. This is due to related electrical configuration and undergoing construction in the DDB-PDEA compound.

Pleases reschedule any planned activities using information systems of the DDB during the scheduled downtime. For any concerns, you may send an email at misd.helpdesk@ddb.gov.ph.

 

Advisory for Electrical Restoration and Maintenance

Electrical restoration and maintenance is going on at the DDB-PDEA compound. Power outages were experienced since this morning due to problems in a major electrical source. Onsite and online transactions with the agency are currently affected. Restoration of services will be announced once the power issues are resolved.

Advisory for August 06, 2022

Information Systems of the Dangerous Drugs Board including its website and online portals will be temporarily unavailable this weekend, 6-7 August 2022, for preventive maintenance and servicing.

Please re-schedule any activities using information systems of the DDB during the scheduled downtime. For any concerns, you may send an email at misd.helpdesk@ddb.gov.ph.

 

Advisory for October 12, 2022

Please be advised that the Dangerous Drugs Board’s trunkline numbers are temporarily unavailable due to some unforeseen event. We are closely working with the telecommunication provider concerned for the immediate resumption of operations of our trunkline numbers.

We apologize for the inconvenience that this incident has caused our clients and stakeholders.

For some concerns relative with our services, we highly encourage everyone to reach us in our email address at: info@ddb.gov.ph

 

Advisory for November 25, 2022

Please be advised that the Dangerous Drugs Board’s trunkline numbers are temporarily unavailable due to some unforeseen event. We are closely working with the telecommunication provider concerned for the immediate resumption of operations of our trunkline numbers.

We apologize for the inconvenience that this incident has caused our clients and stakeholders.

For some concerns relative with our services, we highly encourage everyone to reach us in our email address at: info@ddb.gov.ph

 

Advisory for December 19, 2022

 

ADVISORY!

Please be advised that the Dangerous Drugs Board’s trunkline numbers are temporarily unavailable due to some unforeseen event. We are closely working with the telecommunication provider concerned for the immediate resumption of operations of our trunkline numbers.

We apologize for the inconvenience that this incident has caused our clients and stakeholders.

For some concerns relative with our services, we highly encourage everyone to reach us in our email address at: info@ddb.gov.ph

 

ADVISORIES FROM 2021

Submission of IDADIN Semi-Annual Report (SAR) through Electronic Mail and the Dangerous Drugs and Controlled Precursors & Essential Chemicals Monitoring System (DDCPEC-MS)

The Dangerous Drugs Board, together with the Philippine Drug Enforcement Agency, is pleased to inform its stakeholders of the online reporting system called the Dangerous Drugs and Controlled Precursors and Essential Chemicals Monitoring System or DDCPEC-MS. This system will now be used in submitting reports.

As part of the pilot test and parallel implementation starting 3 January 2022, we request all importers, exporters, manufacturers and distributors of dangerous drugs, controlled precursors and essentials chemicals, and mixtures and products containing dangerous drugs, controlled precursors and essential chemicals, chemical mixtures, and preparations to submit your IDADIN Semi-Annual Report through the DDCPEC-MS and through electronic mail.

Click this link to submit through the DDCPEC-MS, https://ddcpec.ddb.gov.ph/Security/SignIn.aspx. First-time users will have to register their account on the system. For any concerns or inquiries regarding the use of the system, you may send an email to misd.helpdesk@ddb.gov.ph.

Email submissions should be sent concurrently to the following email addresses: lad@ddb.gov.ph and cs.sar@pdea.gov.ph

The submission of the Semi-Annual Report must be done not later than 15 January 2022.

 

Submission of IDADIN Semi-Annual Report

All importers, exporters, manufacturers and distributors of dangerous drugs, controlled precursors and essentials chemicals, and mixtures and products containing dangerous drugs, controlled precursors and essential chemicals, chemical mixtures, and preparations are advised to submit their respective reports using the required IDADIN form through email at legaldivision.ddb@gmail.com not later than 15 January 2021.

Advisory Re: MC No. 85, S. 202

Please click here to view on the March 24, 2021 Advisory.

Online Payment

The Dangerous Drugs Board is pleased to announce online payment options available in partnership with the Land Bank of the Philippines.

    

 

Advisory for April 4, 2021

Please click here  to view on the April 4, 2021 Advisory.

ADVISORIES FROM 2020

 

Advisory for Walk-in Clients to Legal Affairs Division for November 23, 2020

Advisory for Walk-in Clients to Legal Affairs Division for November 23, 2020

 

 

 

Advisory on Payment to Cashier Section for November 23, 2020

 

 

 

 

Centralized Board Secretariat Functions

Advisory for July 28, 2020

Please click here to view on the July 28, 2020 Advisory.

 

Advisory for July 2, 2020

Please click here to view on the July 2, 2020 Advisory.

Online Application for Certification and Exemption Information System

On the use of Ordinary Prescription Forms in prescribing dangerous drugs during the duration of the State of Public Health Emergency under Proclamation No. 922

Please click here to view on the use of Ordinary Prescription Forms in prescribing dangerous drugs during the duration of the State of Public Health Emergency under Proclamation No. 922.

Amendment of advisory dated 18 March 2020 with the subject, “Use of Electronic Prescription for Dangerous Drugs during the duration of the State of Calamity pursuant to Proclamation No. 929 of the Office of the President”

Please click here to view the amendment of advisory dated 18 March 2020 with the subject, “Use of Electronic Prescription for Dangerous Drugs during the duration of the State of Calamity pursuant to Proclamation No. 929 of the Office of the President”.

Use of Electronic Prescription for Dangerous Drugs during the duration of the State of Calamity pursuant to Proclamation No. 929 of the Office of the President

Please click here to view the advisory on the use of Electronic Prescription for Dangerous Drugs during the duration of the State of Calamity pursuant to Proclamation No. 929 of the Office of the President.

Advisory for Applicants of Certificate for Non-Controlled Chemicals and Certificate of Exemption for Products or Chemical Mixtures that Contained Controlled Substances in line with the “Enhanced Community Quarantine” being implemented in the entire Luzon

The Dangerous Drugs Board shall be implementing the following measures to minimize the risk of exposure of all stakeholders to the COVID-19 virus:

For clients of the Dangerous Drugs Board

1. The validity of Certificates for Non-Controlled Chemicals and Exemptions for Chemical Mixtures, Finished Products, and Preparations Containing Controlled Precursors and Essential Chemicals, which will be expiring on the duration of the declared enhanced community quarantine (starting 16 March 2020), shall be extended until fifteen (15) days after the lifting of the Public Health Emergency Declaration.
2. In the meantime, new applications for Certificates and Exemptions, including the required attachments, shall be sent thru email at mtfelix@ddb.gov.ph. Clients are advised to monitor the status of their applications through the ACEDS portal at www.ddb.gov.ph using the assigned transaction number.
3. Collection of fees for Certificates and Exemptions shall be processed as delayed payment/s upon normalization of government operations when the Public Health Emergency Declaration is lifted.

For clients of the Philippine Drug Enforcement Agency

4. The validity of Licenses of registered entities especially in affected areas of the declaration, which are set to expire on the duration of the community quarantine (as stated in item 1 of this Advisory), shall be extended until fifteen (15) days after the lifting of the Public Health Emergency Declaration. No penalty shall be charged provided that the License/s is/are renewed within the said period.
5. Collection of fees for Permits under Article III of DDB Regulation No. 1, Series of 2014 (i.e. Import, Export, Transit Permits) shall be processed as delayed payment/s upon normalization of government operations when the Public Health Emergency Declaration is lifted.
6. In lieu of the Local Order Permit, entities shall adopt an alternative recording system, supported by purchase orders and other relevant documents, which shall be subject to inspection upon normalization of government operations.

Issued this 17th day of March 2020 in Quezon City, Philippines.

By the Authority of the Chairman:

Undersecretary EARL P. SAAVEDRA
Executive Director

Click here to download the advisory.

Submission of IDADIN Report (06 January 2020)

All licensed importers, exporters, manufacturers, and distributors of dangerous drugs / preparations shall submit semi – annual reports to the Dangerous Drugs Board pursuant to Section 4(d) of Regulation No. 7, s 2006 (Subject: Institutionalizing the Dangerous Drugs Board Integrated Drug Abuse Data Information Network) using DDB IDADIN Form 4-06.

Further, all licensed importers, exporters, manufacturers, and distributors of controlled precursors and essential chemicals / mixtures shall submit semi – annual reports to the Dangerous Drugs Board pursuant to the aforesaid Regulation using DDB IDADIN Form 5-06.

Refusal or failure to comply with the Regulation shall be considered a violation of Section 32 of RA No. 9165 or the Comprehensive Dangerous Drugs Act of 2002, as amended, with a penalty of imprisonment ranging from Ten Thousand Pesos (Php 10,000.00) to Fifty Thousand Pesos (Php 50,000.00)

Please be guided accordingly.

Undersecretary EARL P. SAAVEDRA, MPA
Executive Director

 

 

 

NEWSROOM ARCHIVE FROM 2013-2022

 

CITIZEN’S CHARTER 2021 1st edition

CITIZEN’S CHARTER 2022 2nd edition